Last updated on

Research Hotspot & Journal Scope - Recurrent

Pancreas - DOI: 10.1097/MPA.0000000000001350
Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator–Related Disorders

Christina Baldwin · Melissa Zerofsky · Meghana Sathe · David M Troendle · Emily R Perito ·

Pancreas - DOI: 10.1097/MPA.0000000000001243
Role of Diagnostic Endoscopic Ultrasound in Idiopathic Acute Pancreatitis and Acute Recurrent Pancreatitis in Children

Srikanth Puttaiah Kadyada · Babu Ram Thapa · Narendra Dhaka · Anmol Bhatia · Jagadeesh Menon ·

Biology Medicine
Pancreas - DOI: 10.1097/MPA.0000000000001370
SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial

Gregory A Coté · Valerie L Durkalski-Mauldin · Jose Serrano · Erin Klintworth · April W Williams · Zobeida Cruz-Monserrate · Mustafa Arain · James L Buxbaum · Darwin L Conwell · Evan L Fogel · Martin L Freeman · Timothy B Gardner · Erwin van Geenen · J Royce Groce · Sreenivasa S Jonnalagadda · Rajesh N Keswani · Shyam Menon · Dana C Moffatt · Georgios I Papachristou · Andrew Ross · Paul R Tarnasky · Andrew Y Wang · C Mel Wilcox · Frank Hamilton · Dhiraj Yadav ·


Survivors showed little change in the odds of recurrent venous thromboembolism (odds ratio 0.

Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study [10.1136/bmj.l4416]

Recurrent neural networks (RNN) and its subclasses have been demonstrated to be well suited for creating prediction models.

Exploiting Event Log Event Attributes in RNN Based Prediction [10.1007/978-3-030-46633-6_4]

BACKGROUND AND PURPOSE Re-irradiation might yield local control (LC) or palliation for locoregionally recurrent rectal cancer (LRRC), but iatrogenic complications are a possible hindrance.

Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: A meta-analysis and systematic review. [10.1016/j.radonc.2019.05.021]

Viral therapy hypothetically confers significant promise in the treatment of recurrent ovarian cancer, especially in patients who remain unresponsive to traditional medications.

Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patient. [10.1097/CAD.0000000000000836]

INTRODUCTION The aim of this study was to investigate the association of prostate-specific antigen (PSA) values on metastasis-free survival (MFS) in men with biochemically recurrent prostate cancer (BRPC) and PSA doubling time (PSADT) < 12 months.

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. [10.1016/J.CLGC.2019.08.002]

Highly Related Keywords from Recurrent

Research Hotspot


Research Hotspot
Pancreas Related Journals

Popular Journals